SCHEMBL17916148

SCHEMBL17916148

Cc1cc(Cl)c(=O)[nH]n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cetohexazine SCHEMBL2734313 0.76 — —
SCHEMBL101908 0.76 — —
SCHEMBL5843874 0.73 — —
SCHEMBL20743794 0.73 — —
SCHEMBL20206805 0.73 — —
SCHEMBL13351320 0.73 — —
SCHEMBL8480598 0.71 GRIN2D (0.45) —
SCHEMBL183222 0.70 — —
SCHEMBL9451867 0.70 GRIN2D (0.37) —
SCHEMBL9451872 0.70 GRIA1 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9695182-B2 Chemical compounds (derivatives) and their application for the treatment of oncological diseases LIMITED LIABILITY COMPANY “NATIONAL PHARMACEUTICAL TECHNOLOGIES” (RU) 2017-07-04 — — US disclosed
US-20160200729-A1 NEW CHEMICAL COMPOUNDS (DERIVATIVES) AND THEIR APPLICATION FOR THE TREATMENT OF ONCOLOGICAL DISEASES LIMITED LIABILITY COMPANY (RU) 2016-07-14 — — US disclosed
Send feedback